MetaVia, Inc. (MTVA)
1.84
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 13:15
MetaVia Total Assets (Quarterly) : 13.27M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.27M |
| March 31, 2026 | 14.39M |
| December 31, 2025 | 69.12M |
| September 30, 2025 | 14.76M |
| June 30, 2025 | 18.46M |
| March 31, 2025 | 12.13M |
| December 31, 2024 | 16.26M |
| September 30, 2024 | 22.15M |
| June 30, 2024 | 28.75M |
| March 31, 2024 | 17.02M |
| December 31, 2023 | 22.78M |
| September 30, 2023 | 26.42M |
| June 30, 2023 | 29.18M |
| March 31, 2023 | 31.49M |
| December 31, 2022 | 33.53M |
| September 30, 2022 | 7.557M |
| June 30, 2022 | 10.08M |
| March 31, 2022 | 13.46M |
| December 31, 2021 | 16.80M |
| September 30, 2021 | 8.077M |
| June 30, 2021 | 10.72M |
| Date | Value |
|---|---|
| March 31, 2021 | 14.16M |
| December 31, 2020 | 10.97M |
| September 30, 2020 | 13.20M |
| June 30, 2020 | 15.55M |
| March 31, 2020 | 11.54M |
| December 31, 2019 | 14.47M |
| September 30, 2019 | 2.048M |
| June 30, 2019 | 4.014M |
| March 31, 2019 | 6.158M |
| December 31, 2018 | 19.69M |
| September 30, 2018 | 24.87M |
| June 30, 2018 | 28.81M |
| March 31, 2018 | 34.84M |
| December 31, 2017 | 19.02M |
| September 30, 2017 | 26.21M |
| June 30, 2017 | 23.00M |
| March 31, 2017 | 29.84M |
| December 31, 2016 | 24.75M |
| September 30, 2016 | 28.92M |
| June 30, 2016 | 6.726M |
| March 31, 2016 | 2.637M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.995B |
| aTyr Pharma, Inc. | 69.82M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.449M |
| Shareholders Equity (Quarterly) | 6.822M |
| Debt to Equity Ratio | 0.0259 |
| Current Ratio | 2.059 |
| Net Debt Paydown Yield | -0.13% |